What treats congenital nonspherocytic hemolytic anemia?

Our catalog lists 2 products that may treat congenital nonspherocytic hemolytic anemia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.

What is the best-rated treatment for congenital nonspherocytic hemolytic anemia?

Ratings appear as FDA recall-safety data accumulates for the products that may treat congenital nonspherocytic hemolytic anemia.

How are these treatments ranked?

By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

Best treatments for congenital nonspherocytic hemolytic anemia

2 products may treat congenital nonspherocytic hemolytic anemia. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 2 drugs we list for congenital nonspherocytic hemolytic anemia, none are yet flagged as generics in our price data. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for congenital nonspherocytic hemolytic anemia — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated June 7, 2026·How we rate

Treatments we list for congenital nonspherocytic hemolytic anemia
#	Drug	Rating	Type	Form	Class	Generic?	Pharmacy pays
1	Aqvesme Boxed warning	Not yet rated	Prescription	Tablet	—	No data	—	View →
2	Pyrukynd Boxed warning	Not yet rated	Prescription	Tablet	—	No data	—	View →

Full ranking · 2 treatments

aqvesme

Boxed warning

PrescriptionFDA-sourced

New

Aqvesme (Mitapivat Sulfate) is a medication used to treat Hemolytic Anemia, Congenital Nonspherocytic Hemolytic Anemia, Inborn Errors Pyruvate Metabolism.

anemia, hemolyticanemia, hemolytic, congenital nonspherocyticpyruvate metabolism, inborn errors

Price varies

View details →

pyrukynd

Boxed warning

PrescriptionFDA-sourced

New

Pyrukynd (Mitapivat Sulfate) is a medication used to treat Hemolytic Anemia, Congenital Nonspherocytic Hemolytic Anemia, Inborn Errors Pyruvate Metabolism.

anemia, hemolyticanemia, hemolytic, congenital nonspherocyticpyruvate metabolism, inborn errors

Price varies

View details →

Frequently asked

What treats congenital nonspherocytic hemolytic anemia?: Our catalog lists 2 products that may treat congenital nonspherocytic hemolytic anemia, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists.
What is the best-rated treatment for congenital nonspherocytic hemolytic anemia?: Ratings appear as FDA recall-safety data accumulates for the products that may treat congenital nonspherocytic hemolytic anemia.
How are these treatments ranked?: By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.